Hypha Labs Shifts Focus Amid Significant Losses and No Revenue Following Subsidiary Sale

Hypha Labs, Inc. (OTCBB: DIGP) has recently undergone significant changes following the sale of its subsidiary, Digipath Labs, which led to a strategic shift away from cannabis testing to focus on the development of its new product, the Hypha Micropearl accelerator.

Key Points and Statistics:

• Current Cash: $21,093 as of March 31, 2025.
• Negative Working Capital: $1,546,801.
• Accumulated Deficit: $22,528,889.
• Total Revenues (Q2 2025): $0 (no revenue for the quarter).
• Operating Loss (Q2 2025): $669,162, up from a loss of $574,047 in Q2 2024.
• Total Operating Expenses (Q2 2025): $669,162 versus $574,047 in Q2 2024, reflecting increased professional fees.
• Net Loss from Continuing Operations: $(641,822) against $(56,708) in Q2 2024.
• Total Stockholders' Deficit: $(1,817,237) as of March 31, 2025.

Positive Aspects:

• Hypha Labs is pivoting towards an innovative product line with the Hypha Micropearl accelerator, which targets the home production of functional mushrooms, showing potential for growth in the health and wellness foods market.
• Reduction in general administrative expenses by 64% year-over-year indicates improved operational efficiency.
• Professional fees incorporate $389,063 in non-cash stock-based compensation highlighting the Company's strategic investment in human capital.

Negative Aspects:

• No revenues were generated in both Q2 2025 and Q2 2024, raising concerns about the Company's ability to generate income post-restructuring.
• Marked increase in operating loss due to escalating professional fees and a significant rise in general administrative costs by 489% compared to the same period last year.
• Ongoing concerns about liquidity, with cash flow challenges evident due to negative working capital and reliance on financing for operations.

Hypha Labs' transition appears challenging with a current reliance on speculative future revenues from the Micropearl accelerator amidst significant losses and operational restructuring. The lack of revenues post-divestiture raises substantial concerns about sustainability without securing additional capital or successful product launches.